Parametric Portfolio Associates’s Filana Therapeutics FLNA Stock Holding History

Parametric Portfolio Associates’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$526K	Sell	14,159 -4,699	-25%	-$199K	﹤0.01%	3079
2021 Q4	$824K	Buy	18,858 +3,616	+24%	+$190K	﹤0.01%	2862
2021 Q3	$946K	Buy	15,242 +147	+1%	+$12.3K	﹤0.01%	2825
2021 Q2	$1.29M	Sell	15,095 -12,753	-46%	-$683K	﹤0.01%	2658
2021 Q1	$1.25M	Buy	+27,848	New	+$1.1M	﹤0.01%	3051
2016 Q1	–	Sell	-1,504	Closed	-$18K	–	4019
2015 Q4	$18K	Hold	1,504	–	–	﹤0.01%	3939
2015 Q3	$19K	Sell	1,504 -1,520	-50%	-$19.2K	﹤0.01%	3256
2015 Q2	$37K	Buy	3,024 +1,387	+85%	+$19K	﹤0.01%	3938
2015 Q1	$22K	Buy	+1,637	New	+$22.1K	﹤0.01%	3926

Other funds holding FLNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Parametric Portfolio Associates's FLNA Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Filana Therapeutics (FLNA) stake by 25% in Q1 2022, selling an estimated $199K and leaving 14,159 shares worth $526K. The position accounts for ﹤0.01% of the portfolio, ranked #3079.

Parametric Portfolio Associates first reported a position in FLNA in Q1 2015 and has held it in 9 quarters since. The position peaked at $1.29M in Q2 2021. 163 funds tracked by Wall St. Rank hold FLNA as of Q1 2022.

Parametric Portfolio Associates held 14,159 shares of Filana Therapeutics worth $526K as of Q1 2022.
Parametric Portfolio Associates sold 4,699 Filana Therapeutics shares in Q1 2022, an estimated $199K.
Filana Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3079 holding.
Parametric Portfolio Associates first reported a position in Filana Therapeutics in Q1 2015 and has held it in 9 quarters since.
Parametric Portfolio Associates's Filana Therapeutics position peaked at $1.29M in Q2 2021.
163 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.